Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Authors

Showing 6 results for author "Rithika Manjunatha Reddy".

Back to authors

Thumbnail for Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

CLL - 083

Cardiovascular and Infectious Toxicities Associated With Targeted Therapies in Chronic Lymphocytic Leukemia

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Clinical Predictors of Severe Cytokine Release Syndrome in CAR T-Cell Therapy for B-Cell Malignancies: A Systematic Review and Meta-Analysis

CT - 071

Clinical Predictors of Severe Cytokine Release Syndrome in CAR T-Cell Therapy for B-Cell Malignancies: A Systematic Review and Meta-Analysis

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Duration of Minimal Residual Disease Negativity Predicts Durable Disease Control in Multiple Myeloma: A Meta-Analysis of 8900 Patients

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MM - 072

Duration of Minimal Residual Disease Negativity Predicts Durable Disease Control in Multiple Myeloma: A Meta-Analysis of 8900 Patients

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

$Thumbnail for Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 079

Treatment Discontinuation and Dose Modifications Associated With Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

MM - 089

Is IgA Isotype an Independent Adverse Prognostic Factor in Multiple Myeloma? A Systematic Review and Meta-Analysis of Cytogenetic Risk, Survival, and Treatment Outcomes in the Modern Era

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

Thumbnail for Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

MM - 130

Does Minimal Residual Disease Negativity Overcome High-Risk Cytogenetics After Autologous Stem Cell Transplantation in Multiple Myeloma?

Rithika Manjunatha Reddy

Poster Presenter: Rithika Manjunatha Reddy

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors